The Carcinogenic Properties of Some of the Principal Drugs Used in Clinical Cancer Chemotherapy
Authors:
- J. H. WeisburgerJWJ. H. Weisburger
- D. P. GriswoldDGD. P. Griswold
- J. D. PrejeanJPJ. D. Prejean
- A. E. CaseyACA. E. Casey
- H. B. WoodHWH. B. Wood
- E. K. WeisburgerEWE. K. Weisburger
- 1 January 1975
- book chapter
- Published by Springer Nature
- No. 52,p. 1-17
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- On the Biological Alkylating AgentsPerspectives in Biology and Medicine, 1973
- Occurrence of malignancy in immunodeficiency diseases: A literature reviewCancer, 1971
- Pancreatic Islet Cell Tumors Produced by the Combined Action of Streptozotocin and NicotinamideExperimental Biology and Medicine, 1971
- Induction of thymic lymphosarcoma and mammary adenocarcinomas in rats by oral administration of the antitumor agent4(5)-(3,3-dimethyl-l-triazeno)imidazole-5(4)-carboxamideCancer, 1970
- CARCINOGENIC EPOXIDES, LACTONES, AND HALO‐ETHERS AND THEIR MODE OF ACTION*Annals of the New York Academy of Sciences, 1969
- Potential Carcinogenic Hazards from Drugs1967
- Ibenzmethyzin (Natulan®), a highly effective mammary carcinogen in the huggins systemEuropean Journal of Cancer (1965), 1966
- Pulmonary-tumor induction in mice with chemical agents used in the clinical management of lymphomasCancer, 1954
- The growth-inhibitory and carcinogenic properties of 4-aminostilbene and derivativesPhilosophical Transactions of the Royal Society of London. Series A, Mathematical and Physical Sciences, 1948